Entering text into the input field will update the search result below

Trinity Biotech reports Q3 results

  • Trinity Biotech (NASDAQ:TRIB) Q3 results: Revenues: $26.1M (+1.2%); Operating Income: $2.7M (-10.0%); Net Loss: ($0.5M) (-104.1%); Loss Per Share: ($0.02) (-103.8%); Non-GAAP EPS: $0.07 (-12.5%); Quick Assets: $84.8M (-0.1%); CF Ops: $5.6M (+51.4%).
  • No guidance given.

Recommended For You

More Trending News

About TRIB Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
TRIB--
Trinity Biotech plc